RE:RE:Haywood Securities - cantechletter.comdavgro wrote: Many of the recent posts on this board have mentioned due diligence and the importance of an investor in doing their own DD before purchasing a stock. With that in mind it is also important to understand that analysts or newsletters may have a vested interest in promoting a stock.
I always check the track record of these "analysts" to see their past performance for stocks they have recommended. In the same vein I also check to see if their firms have been involved in past public offerings for the company's they recommend. Analyst price targets must be unbiased and include supporting commentary that explains their recommendation and price target in detail.
The Cantech Letter is a paid promotional distribution. That's not to say that they don't provide information that may be of value or interest to investors. That said, WELL investors or prospective investors should take note of the disclaimer at the end of the recent article when performing their due diligence:
"Disclosure: Jayson MacLean and Nick Waddell own shares of WELL Health Technologies and WELL is an annual sponsor of Cantech Letter."
That's why I include the disclaimer always. I don't want budd chewing me out.
"That's not to say that they don't provide information that may be of value or interest to investors."
Very true ; I post them because it may affect stock price.